ANTONIO IGNACIO
FERNÁNDEZ ORTIZ
Profesor asociado de Ciencias de la Salud
José Luis
Ferreiro
José Luis Ferreiro-rekin lankidetzan egindako argitalpenak (5)
2022
-
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
Circulation, Vol. 146, Núm. 16, pp. 1196-1206
-
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial
European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330
2016
-
A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents with Durable Polymer in Patients with Diabetes Mellitus the RESERVOIR Clinical Trial
JACC: Cardiovascular Interventions, Vol. 9, Núm. 1, pp. 42-50
2011
-
Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
Journal of the American College of Cardiology, Vol. 58, Núm. 1, pp. 30-39
2010
-
Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy
Journal of the American College of Cardiology, Vol. 55, Núm. 11, pp. 1139-1146